Bio-Techne Corporation
TECH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $286,555 | $316,964 | $316,181 | $297,031 |
| % Growth | -9.6% | 0.2% | 6.4% | – |
| Cost of Goods Sold | $96,364 | $118,152 | $101,625 | $103,145 |
| Gross Profit | $190,191 | $198,812 | $214,556 | $193,886 |
| % Margin | 66.4% | 62.7% | 67.9% | 65.3% |
| R&D Expenses | $24,241 | $26,032 | $24,579 | $25,016 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $115,162 | $23,216 | $151,269 | $121,451 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $173,424 | $0 | $0 |
| Operating Expenses | $139,403 | $222,672 | $175,848 | $146,467 |
| Operating Income | $50,788 | -$23,860 | $38,708 | $47,419 |
| % Margin | 17.7% | -7.5% | 12.2% | 16% |
| Other Income/Exp. Net | -$2,797 | $1,001 | -$434 | -$4,543 |
| Pre-Tax Income | $47,991 | -$22,859 | $38,274 | $42,876 |
| Tax Expense | $9,806 | -$5,181 | $15,686 | $7,986 |
| Net Income | $38,179 | -$17,678 | $22,588 | $34,890 |
| % Margin | 13.3% | -5.6% | 7.1% | 11.7% |
| EPS | 0.25 | -0.11 | 0.14 | 0.22 |
| % Growth | 327.3% | -178.6% | -36.4% | – |
| EPS Diluted | 0.24 | -0.11 | 0.14 | 0.22 |
| Weighted Avg Shares Out | 155,464 | 154,913 | 157,372 | 158,431 |
| Weighted Avg Shares Out Dil | 156,362 | 154,913 | 158,944 | 160,626 |
| Supplemental Information | – | – | – | – |
| Interest Income | $971 | $585 | $1,026 | $1,348 |
| Interest Expense | $5,468 | $2,178 | $2,007 | $2,148 |
| Depreciation & Amortization | $24,340 | $27,111 | $27,571 | $27,084 |
| EBITDA | $77,799 | $6,430 | $67,852 | $72,108 |
| % Margin | 27.1% | 2% | 21.5% | 24.3% |